BIMI (BIMI) Stock Price & Analysis
BIMI (BIMI) rose 0.00% to USD 0 as of June 10, 2026 at 04:39 UTC, according to Nexqual real-time market data.
BIMI last closed at USD 0; the session ranged USD 0–0 on volume of 26,254 shares. Market capitalization is $1,396, with a 52-week range of USD 0–0.01 (PNK). Source: Nexqual, June 10, 2026 at 04:39 UTC.
Key Statistics (as of June 10, 2026 at 04:39 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.01 |
| Volume | 26,254 shares |
| Market Cap | $1,396 |
| Exchange | PNK |
Technical Analysis (BIMI)
Nexqual's technical model rates BIMI "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 04:39 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (BIMI)
Wall Street analysts rate BIMI "None", per Nexqual as of June 10, 2026 at 04:39 UTC.
| Consensus Rating | None |
|---|
Earnings (BIMI)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2011-06-30 | USD 4.5 vs est 16.5 ▼ miss |
| 2011-03-31 | USD 2.5 vs est 7 ▼ miss |
| 2010-12-31 | USD 4.5 vs est 16.5 ▼ miss |
| 2010-09-30 | USD 19 vs est 19 ▲ beat |
Source: Nexqual, June 10, 2026 at 04:39 UTC.
Financials & Fundamentals (BIMI)
| Total Revenue | $12.63M |
|---|---|
| Revenue Growth (YoY) | -48.80% |
| Gross Margin | +40.30% |
| Operating Margin | -124.83% |
| Profit Margin | -83.20% |
| ROE | -103.78% |
| Debt / Equity | 49.25 |
| Current Ratio | 1.21 |
| Total Cash | $994,131 |
| Total Debt | $4.99M |
| Free Cash Flow | $-5.75M |
Source: Nexqual, June 10, 2026 at 04:39 UTC.
Financial Health Score (BIMI)
Nexqual rates BIMI's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 04:39 UTC.
| Growth | Critical — Revenue -49% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Solid — $994K cash vs $5M debt |
| Cash Flow | Weak — FCF negative: -$6M, burning cash |
| Efficiency | Critical — ROE -104%, ROA -13.0% |
Ownership (BIMI)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 13.96M |
| Float | 1.81M |
| Short % of Float | +2.57% |
Source: Nexqual, June 10, 2026 at 04:39 UTC.
Leadership (BIMI)
BIMI is led by Tiewei Song (age 53), CEO & Director, per Nexqual as of June 10, 2026 at 04:39 UTC.
| CEO & Director | Tiewei Song (age 53) |
|---|---|
| Interim Chief Financial Officer | Baiqun Zhong (age 61) |
| Chief Operating Officer | Xiaoping Wang (age 44) |
| Chairman of Board & President | Fnu Oudom (age 70) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SXTC | China SXT Pharmaceuticals, Inc. | USD 1.56 | ▲ 8.33% |
| AIHS | Senmiao Technology Limited | USD 1.33 | ▲ 15.65% |
| GRNQ | Greenpro Capital Corp. | USD 1.51 | ▼ 1.31% |
| PETZ | TDH Holdings, Inc. | USD 1.22 | ▲ 3.39% |
| DTSS | Datasea Intelligent Technology | USD 0.92 | ▲ 9.52% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 04:39 UTC. This page is informational and not investment advice.